2) Carcinoma of endometrium
子宫内膜癌
1.
Different expression of a synthetic enzymen for L-selectin ligant in the endometrium from the patients with carcinoma of endometrium and normal women;
一种L-选择素配体合成酶在子宫内膜癌和正常子宫内膜中的差异表达
2.
Clinical value of TSGF in carcinoma of endometrium;
肿瘤特异性生长因子在子宫内膜癌的应用价值
3.
Oncogene expression in tumor tissue from patients with carcinoma of endometrium and its clinical significance;
子宫内膜癌患者瘤组织某些肿瘤相关基因的表达及其临床意义
3) Endometrial Cancer
子宫内膜癌
1.
Preoperative assessment of cervical invasion in endometrial cancer:comparison of MRI and D&C;
分段诊刮与核磁共振术前诊断子宫内膜癌宫颈浸润的比较
2.
Case-control study on IUD use and endometrial cancer risk;
宫内节育器与子宫内膜癌病例对照研究
3.
Real-time quantitative RT-PCR detection of lymph node micrometastases of patients with endometrial cancer.;
应用实时定量RT-PCR方法检测子宫内膜癌患者盆腔淋巴结中微转移的探讨
4) endometrial carcinoma
子宫内膜癌
1.
Detection of phosphorylated extra-cellular signal-regulated kinase in human endometrial carcinomas tissue;
人子宫内膜癌组织中磷酸化细胞外信号调节激酶的检测
2.
Clinical value of combined detection of CA_(125) and CA_(153) in endometrial carcinoma;
联合检测CA_(125)与CA_(153)对子宫内膜癌的临床价值
3.
Analysis of magnetic resonance imaging in evaluating the myometrium invasion of endometrial carcinoma;
磁共振成像诊断子宫内膜癌肌层浸润深度
5) endometrium cancer
子宫内膜癌
1.
Clinical study of preoperative chemotherapeutic infusion by artery catheterization for endometrium cancer;
子宫内膜癌术前动脉插管化疗临床研究
2.
Effect of pseudo CO_2 pneumoperitoneum on cell adhesion capability of cultured endometrium cancer cells;
模拟CO_2气腹对人子宫内膜癌细胞黏附能力的影响
3.
Distribution of cell cycle and expression of P53 protein in endometrium cancer tissues;
子宫内膜癌组织细胞周期分布与P53蛋白的表达
6) Endometrial adenocarcinoma
子宫内膜癌
1.
Effect of all trans retinoic acid on MMP-9 expression in human endometrial adenocarcinoma cell line RL95-2;
全反式维甲酸对人子宫内膜癌细胞MMP-9表达影响的研究
2.
Insulin-like growth factor-1 receptor expression and their clinical significance in endometrial adenocarcinoma;
胰岛素样生长因子-1受体在子宫内膜癌中的表达及临床意义
3.
Objective To study the expression and role of β-catenin and APC protein in endometrial adenocarcinoma.
05);β-catenin阳性表达率与子宫内膜癌的临床分期、病理分型密切相关;子宫内膜腺癌、子宫内膜增生症可见核表达,表达率分别为(30。
补充资料：卵巢宫内膜样腺癌
卵巢宫内膜样腺癌
与子宫内膜腺癌组织结构极相似，可能来源于卵巢生发上皮向子宫内膜样上皮化生。1964年FIGO正式命名，1973年WHO组织学分型中正式分出良性、交界性及恶性卵巢宫内膜样肿瘤，以恶性出现居多。其组织表现与子宫体的子宫内膜癌极相似，后者的所有类型均可发生。占卵巢恶性肿瘤的16%～31%。单侧较多，囊实性或大部实性，有的伴有巧克力囊肿。大小不等，切面灰白色，常有出血。根据腺体形态，核分裂象及实性部分分成高、中、低分化，即G1、G2及G3。诊断原发卵巢宫内膜样癌须与来自子宫内膜癌的转移鉴别。除盆腔肿块、腹胀及腹痛外，也常伴有腹水、不规则阴道出血等症状。治疗应按临床分期及病理分级等决定手术，即细胞减灭术，术后辅以化疗。预后较浆液性或黏液性腺癌略好。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条